Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-02

Clinical Trial Update: Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating the combined effects of a GLP-1 analogue and exercise on maintaining weight loss after a very-low-calorie diet in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 analogue (GLP-1 analogue)

Snippet

Sponsor: Signe Torekov | Conditions: Obesity | Phase 4 | Status: UNKNOWN